Pfizer Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

45.75

45.75

45.75

45.75

45.75

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

3,161.55

2,818.66

2,347.29

3,349.74

2,965.59

Loan funds

Secured loans

2.50

2.50

2.50

2.50

2.50

Unsecured loans

-

-

-

-

-

Total

3,209.80

2,866.91

2,395.54

3,397.99

3,013.84

Uses of funds

Fixed assets

Gross block

978.90

1,050.27

1,035.22

1,074.42

946.23

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

229.65

181.14

140.92

101.56

60.04

Net block

749.25

869.13

894.30

972.86

886.19

Capital work-in-progress

7.93

1.15

2.76

0.76

-

Investments

-

-

-

-

-

Net current assets

Current assets, loans & advances

3,243.55

3,030.23

2,368.84

3,431.78

3,053.80

Less : current liabilities & provisions

790.93

1,033.60

870.36

1,007.41

926.15

Total net current assets

2,452.62

1,996.63

1,498.48

2,424.37

2,127.65

Miscellaneous expenses not written

-

-

-

-

-

Total

3,209.80

2,866.91

2,395.54

3,397.99

3,013.84

Notes:

Book value of unquoted investments

-

-

-

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

437.83

338.14

254.98

254.60

219.12

Number of equity sharesoutstanding (Lacs)

457.48

457.48

457.48

457.48

457.48